Charleston, South Carolina30+ days ago
Combining animal models with high-throughput transcriptomics/proteomics approaches, bioinformatics/modeling tools and clinical sample analyses, our dynamic group focuses on identifying novel targets overcoming resistance to state-of-art clinically approved or -tested drugs and preventing metastatic spread of breast cancer. Cancer Research, 2024, doi.org/10.1158/0008-5472.CAN-23-2812, Nature Communications, 2023, doi: 10.1038/s41467-023-42736-y, Cell Death & Differentiation, 2023, doi: 10.1038/s41418-023-01140-1).